CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02469896
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:28.235843+00:00
- Published At
- 2019-12-18T00:00:00+00:00
- Record Updated At
- 2019-12-18
- Results Posted At
- 2019-12-18
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["ALS", "Amyotrophic Lateral Sclerosis", "Lou Gehrig\u0027s Disease", "Motor Neuron Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-12-18"- protocolSection.identificationModule.nctId
"NCT02469896"- protocolSection.identificationModule.officialTitle
"A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-12-18"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.